The Best Practices for Screening, Monitoring, and Diagnosis of Cytomegalovirus Disease, Part II

Clinical Microbiology Newsletter

Volumn 32, Issue 2, 2010, Pages 9-15

  Lazzarotto, Tiziana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS VACCINE; GANCICLOVIR; IMMUNOGLOBULIN G; PLACEBO; VALACICLOVIR;

AMNIOCENTESIS; ANTIBODY DETECTION; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; FETUS ECHOGRAPHY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGICAL MONITORING; INCIDENCE; INFECTION CONTROL; INFECTION RISK; NEWBORN INFECTION; PATIENT COUNSELING; PERINATAL MORTALITY; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; PREPREGNANCY CARE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEROLOGY; SYMPTOMATOLOGY; TREATMENT DURATION; VIROLOGY; VIRUS TRANSMISSION;

EID: 72649106605     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2009.12.004     Document Type: Article

References (28)

1. Kenneson A., and Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17 (2007) 253-276
2. Boppana S., et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. 11 (1992) 93-99
3. Fowler K.B., et al. The outcome of congenital cytomegalovirus in relation to maternal antibody status. N. Engl. J. Med. 326 (1992) 663-667
4. Bodeus M., et al. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet. Gynecol. 93 (1999) 658-660
5. Pass R.F., et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35 (2006) 216-220
6. Revello M.G., and Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev. 15 (2002) 680-715
7. Dahle A.J., et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11 (2000) 283-290
8. Gabrielli L., et al. Histological findings in foetuses congenitally infected by cytomegalovirus. J. Clin. Virol. 46 Suppl. 4 (2009) S16-S21
9. Coll O., et al. Guidelines on CMV congenital infection. J. Perinat. Med. 37 (2009) 433-445
10. Adler S.P., et al. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J. Pediatr. 145 (2004) 485-491
11. Lazzarotto T., et al. New advances in the diagnosis of congenital cytomegalo virus infection. J. Clin. Virol. 41 (2008) 192-197
12. Macé M., et al. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenat. Diagn. 24 (2004) 861-863
13. Lazzarotto T., et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol. 13 (2000) 137-141
14. Lilleri D., et al. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J. Infect. Dis. 195 (2007) 1062-1070
15. Guerra B., et al. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am. J. Obstet. Gynecol. 196 (2007) 221.e1-221.e6
16. Benoist G., et al. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. Br. J. Obstet. Gynecol. 115 (2008) 823-829
17. Nanal R., et al. A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix. Prenat. Diagn. 23 (2003) 488-492
18. Enders G., et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat. Diagn. 21 (2001) 362-377
19. Lazzarotto, T. et al. 2009. Prenatal diagnosis of congenital cytomegalovirus (CMV) infection and outcome in 598 pregnant women undergoing a primary CMV infection. OR 10.2. In Abstracts of the 12th International CMV/BetaHerpesvirus Workshop, 10-14 May 2009, Boston, MA.
20. Lanari M., et al. Neonatal cytomegalovirus blood load and risk of sequele in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117 (2006) e76-e83
21. Barbi M., et al. Diagnosis of congenital CMV infection via dried blood spots. Rev. Med. Virol. 16 (2006) 385-392
22. Boppana S. Newborn CMV screening: NIDCD CHIMES Study. Congenital Cytomegalovirus Conference 2008, Atlanta, GA, 5-7 November 2008. http://www.congenitalcmv.org.htm
23. Rosenthal L.S., et al. Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr. Infect. Dis. J. 28 (2009) 515-520
24. Nigro G., et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 353 (2005) 1350-1362
25. Jacquemard F., et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. Br. J. Obstet. Gynecol. 114 (2007) 1113-1121
26. Kimberlin D.W., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 143 (2003) 16-25
27. Kimberlin D.W., et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J. Infect. Dis. 197 (2008) 836-845
28. Pass R.F., et al. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360 (2009) 1191-1199